Migraña e investigación en epidemiología

Lipton RB. Tracing transformation. Chronic migraine classification, progression and epidemiology. Neurology 2009; 72(Suppl. 1).

Lipton RB, Bigail ME. Epidemiology of Migraine in Latin America: An Editorial. The Journal of Head & Face Pain 2005: 103-104.

Lavados P, Tenhamm E. Epidemiology of migraine headache in Santiago, Chile: a prevalence study. Cephalalgia 1997; 17: 770-777.

Rueda-Sánchez M, Díaz-Martínez L. Prevalence and associated factors for episodic and chronic daily headache in the Colombia Population. Cephalalgia 2008; 28: 216-225.

Muñoz JF. Migraña en Colombia: más conocimiento de nuestro entorno. Acta Neurológica Colombiana 2009; 25(2): 1-2.

Burton WN, Landy SH, Downs KE, Runken MC. The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and suggestions for Future Resarch. Mayo Clinic Proc 2009; 84(5): 436-445.

Michel P, Dartigues J, Duru G, Moreau J, Salmon R, Henry P. Incremental absenteeism due to headaches in migraine: results from the Mig-Acces Frech national cohort. Cephalalgia 1999; 19: 503-510.

Bigal ME, Ferrani M, Silberstein SD, Lipton RB, Goadsby PJ. Migraine in the Triptan Era: Lessons From Epidemiology, Pathophysiology, and Clinical Science. Headache 2009; 49: S21-S33.

Lipton RB, Bigal ME. Ten Lessons on the Epidemiology of Migraine. Headache 2007; Suppl. 1: S2-S9.

Trillos CE. Conceptos básicos de epidemiología, en: Blanco JH, Maya JM, editores. Fundamentos de Salud Pública, segunda ed. Medellín: CIB (Corporación para Investigaciones Biológicas); 2006: 6-29.

Furman J, Balaban C, Jacob R, Marcus D. Migraine anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 2005; 76: 1-8.

D'Onofrio F, Cologno D, Buzzi MG, Petretta V, Caltagirone C, Casucci G. Adult abdominal migraine: a new syndrome or sporadic fature of migraine headache? A case report. European Journal of Neurology 2006; 13: 85-88.

Young W, Hopkins M, Schechter A, Silberstein S. Topiramate: a case series study in migraine prohylaxis. Cephalalgia 2002; 22: 659-663.

Launer L, Terwindt G, Ferrari M. The prevalence and characteristics of migraine in a population-based cohort -The GEM Study. Neurology 2000; 11(53): 537-542.

Géraud G, Valade D, Lantéri-Minet M, Radat F, Lucas C, Vives E et al. SMILE: first observational prospective cohort study of migraine in primary care in France. Description of methods and study population. Cephalalgia 2007; 28: 164-173.

Lipton R, Bigal M, Kolodner K, Stewart W, Liberman J, Steiner T. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003; 23: 429-440.

Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS? A prevalence study. BMC Gastroenterology 2006; 6(26): 1-8.

Ertresvg JM, Stovner LJ, Kvavik LE, Johnsen H-J, Zwart J-A, Helde G et al. Migraine aura or transient ischemic attacks? A five-year follow-up case control-study of women with transient central nervous system disorders in pregnancy. BMC Medicine 2007; 5(19): 1-8.

Waldie KE. Childhood Headache, Stress in Adolescence, and Primary Headache in Young Adulthood: A Longitudinal Cohort Study. Headache 2001; 41:1-10.

Kurt T, Slomke M, Kase C, Cook N, Lee I, Gaziano J et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005; 64: 1020-1026.

Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for Migraine Prevention in Children: A randomized, Double-Bind, Placebo-Controlled Trial. Headache 2005; 45: 1304-1312.

Vécsei L, Gallacchi G, Sági I, Semjén J, Tajti J, Szok D et al. Diclofenac epolamine is effective in the tratment of acute migraine attacks. A randomized, crossover, doublebind, placebo-controlled, clinical study. Cephalalgia 2007; 27: 29-34.

Colman I, Brown M, Innes G, Grafstein E, Roberts T, Rowe B. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med 2005; 45: 393-401.

Van-der-Kuy P-H, Lohman J. A Quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002: 265-270.

Ferrari MD, Roon Ki, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-1675.

Perfetto EM, Weis KA, Mullins D, Subedi P, Healey PJ. An economic evalation of triptan products for migraine. Value in health 2005; 8(6): 647-655.

Ramadan N, Schultz L, Gilkey S. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997; 17: 73-80.